Pulse Biosciences, Inc. Research and Development Expense
Pulse Biosciences, Inc. (PLSE) reported Research and Development Expense of $16.98 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-06
- Pulse Biosciences, Inc. research and development expense for the quarter ending 2026-06-30 was $16.98M, a 40.44% increase year-over-year.
- Pulse Biosciences, Inc. research and development expense for the quarter ending 2026-03-31 was $12.59M, a 22.08% increase year-over-year.
- Pulse Biosciences, Inc. research and development expense for the quarter ending 2025-12-31 was $10.93M, a 2.49% increase year-over-year.
- Pulse Biosciences, Inc. research and development expense for the quarter ending 2025-09-30 was $11.39M, a 47.90% increase year-over-year.
- Pulse Biosciences, Inc. research and development expense for fiscal 2025 was $44.72M, a 38.30% increase from fiscal 2024.
- Pulse Biosciences, Inc. research and development expense for fiscal 2024 was $32.34M, a 16.33% increase from fiscal 2023.
- Pulse Biosciences, Inc. research and development expense for fiscal 2023 was $27.80M, a 33.39% increase from fiscal 2022.
- Pulse Biosciences, Inc. research and development expense for fiscal 2022 was $20.84M, a 27.24% decline from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 7 month | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $16.98M 10-Q · filed 2026-08-06 | $29.57M 10-Q · filed 2026-08-06 | $40.49M derived: sum of 3 quarters · filed 2026-08-06 | $51.89M derived: sum of 4 quarters · filed 2026-08-06 | |||||
| 2026-03-31 | $12.59M 10-Q · filed 2026-05-14 | $23.52M derived: sum of 2 quarters · filed 2026-05-14 | $34.91M derived: sum of 3 quarters · filed 2026-05-14 | $47.00M derived: sum of 4 quarters · filed 2026-08-06 | |||||
| 2025-12-31 | $10.93M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $22.32M derived: sum of 2 quarters · filed 2026-02-19 | $34.41M derived: sum of 3 quarters · filed 2026-08-06 | $44.72M 10-K · filed 2026-02-19 | |||||
| 2025-09-30 | $11.39M 10-Q · filed 2025-11-05 | $23.48M derived: sum of 2 quarters · filed 2026-08-06 | $33.79M 10-Q · filed 2025-11-05 | $44.46M derived: sum of 4 quarters · filed 2026-08-06 | |||||
| 2025-06-30 | $12.09M 10-Q · filed 2026-08-06 | $22.40M 10-Q · filed 2026-08-06 | $33.06M derived: sum of 3 quarters · filed 2026-08-06 | $40.77M derived: sum of 4 quarters · filed 2026-08-06 | |||||
| 2025-03-31 | $10.31M 10-Q · filed 2026-05-14 | $20.98M derived: sum of 2 quarters · filed 2026-05-14 | $28.68M derived: sum of 3 quarters · filed 2026-05-14 | $35.91M derived: sum of 4 quarters · filed 2026-05-14 | |||||
| 2024-12-31 | $10.66M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $18.36M derived: sum of 2 quarters · filed 2026-02-19 | $25.59M derived: sum of 3 quarters · filed 2026-02-19 | $32.34M 10-K · filed 2026-02-19 | |||||
| 2024-09-30 | $7.70M 10-Q · filed 2025-11-05 | $14.93M derived: sum of 2 quarters · filed 2025-11-05 | $21.67M 10-Q · filed 2025-11-05 | $29.47M derived: sum of 4 quarters · filed 2025-11-05 | |||||
| 2024-06-30 | $7.23M 10-Q · filed 2025-08-12 | $13.97M 10-Q · filed 2025-08-12 | $21.77M derived: sum of 3 quarters · filed 2025-08-12 | $29.24M derived: sum of 4 quarters · filed 2025-08-12 | |||||
| 2024-03-31 | $6.74M 10-Q · filed 2025-05-08 | $14.54M derived: sum of 2 quarters · filed 2025-05-08 | $22.01M derived: sum of 3 quarters · filed 2025-05-08 | $28.71M derived: sum of 4 quarters · filed 2025-05-08 | |||||
| 2023-12-31 | $7.80M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $15.27M derived: sum of 2 quarters · filed 2025-03-31 | $21.97M derived: sum of 3 quarters · filed 2025-03-31 | $27.80M 10-K · filed 2025-03-31 | |||||
| 2023-09-30 | $7.47M 10-Q · filed 2024-10-30 | $14.17M derived: sum of 2 quarters · filed 2024-10-30 | $20.00M 10-Q · filed 2024-10-30 | $24.09M derived: sum of 4 quarters · filed 2024-10-30 | |||||
| 2023-06-30 | $6.70M 10-Q · filed 2024-08-19 | $12.53M 10-Q · filed 2024-08-19 | $16.62M derived: sum of 3 quarters · filed 2024-08-19 | $21.14M derived: sum of 4 quarters · filed 2024-08-19 | |||||
| 2023-03-31 | $5.83M 10-Q · filed 2024-05-07 | $9.92M derived: sum of 2 quarters · filed 2024-05-07 | $14.44M derived: sum of 3 quarters · filed 2024-05-07 | $19.90M derived: sum of 4 quarters · filed 2024-05-07 | |||||
| 2022-12-31 | $4.09M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $8.61M derived: sum of 2 quarters · filed 2024-03-28 | $14.07M derived: sum of 3 quarters · filed 2024-03-28 | $20.84M 10-K · filed 2024-03-28 | |||||
| 2022-09-30 | $4.52M 10-Q · filed 2023-11-13 | $9.97M derived: sum of 2 quarters · filed 2023-11-13 | $16.74M 10-Q · filed 2023-11-13 | $22.40M derived: sum of 4 quarters · filed 2023-11-13 | |||||
| 2022-06-30 | $5.46M 10-Q · filed 2023-08-10 | $12.23M 10-Q · filed 2023-08-10 | $17.89M derived: sum of 3 quarters · filed 2023-08-10 | $24.34M derived: sum of 4 quarters · filed 2023-08-10 | |||||
| 2022-03-31 | $6.77M 10-Q · filed 2023-05-11 | $12.43M derived: sum of 2 quarters · filed 2023-05-11 | $18.89M derived: sum of 3 quarters · filed 2023-05-11 | $26.35M derived: sum of 4 quarters · filed 2023-05-11 | |||||
| 2021-12-31 | $5.66M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $12.12M derived: sum of 2 quarters · filed 2023-03-31 | $19.58M derived: sum of 3 quarters · filed 2023-03-31 | $28.64M 10-K · filed 2023-03-31 | |||||
| 2021-09-30 | $6.46M 10-Q · filed 2022-11-10 | $13.92M derived: sum of 2 quarters · filed 2022-11-10 | $22.98M 10-Q · filed 2022-11-10 | $30.41M derived: sum of 4 quarters · filed 2023-03-31 | |||||
| 2021-06-30 | $7.46M 10-Q · filed 2022-08-10 | $16.52M 10-Q · filed 2022-08-10 | $23.95M derived: sum of 3 quarters · filed 2023-03-31 | $30.91M derived: sum of 4 quarters · filed 2023-03-31 | |||||
| 2021-03-31 | $9.06M 10-Q · filed 2022-05-11 | $16.49M derived: sum of 2 quarters · filed 2023-03-31 | $23.46M derived: sum of 3 quarters · filed 2023-03-31 | $29.33M derived: sum of 4 quarters · filed 2023-03-31 | |||||
| 2020-12-31 | $7.42M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $14.39M derived: sum of 2 quarters · filed 2023-03-31 | $20.26M derived: sum of 3 quarters · filed 2023-03-31 | $26.44M 10-K · filed 2023-03-31 | |||||
| 2020-09-30 | $6.97M 10-Q · filed 2021-11-15 | $12.84M derived: sum of 2 quarters · filed 2021-11-15 | $19.02M 10-Q · filed 2021-11-15 | $25.61M derived: sum of 4 quarters · filed 2021-11-15 | |||||
| 2020-06-30 | $5.87M 10-Q · filed 2021-08-09 | $12.05M 10-Q · filed 2021-08-09 | $18.64M derived: sum of 3 quarters · filed 2021-08-09 | $24.83M derived: sum of 4 quarters · filed 2021-08-09 | |||||
| 2020-03-31 | $6.18M 10-Q · filed 2021-05-10 | $12.77M derived: sum of 2 quarters · filed 2021-05-10 | $18.96M derived: sum of 3 quarters · filed 2021-05-10 | $25.30M derived: sum of 4 quarters · filed 2021-05-10 | |||||
| 2019-12-31 | $6.59M 10-K · filed 2020-03-16 | $12.78M derived: sum of 2 quarters · filed 2020-11-09 | $19.12M derived: sum of 3 quarters · filed 2020-11-09 | $24.96M 10-K · filed 2022-03-31 | |||||
| 2019-09-30 | $6.19M 10-Q · filed 2020-11-09 | $12.53M derived: sum of 2 quarters · filed 2020-11-09 | $18.37M 10-Q · filed 2020-11-09 | $23.45M derived: sum of 4 quarters · filed 2020-11-09 | |||||
| 2019-06-30 | $6.34M 10-Q · filed 2020-08-10 | $12.18M 10-Q · filed 2020-08-10 | $17.26M derived: sum of 3 quarters · filed 2020-08-10 | $22.30M derived: sum of 4 quarters · filed 2020-08-10 | |||||
| 2019-03-31 | $5.84M 10-Q · filed 2020-05-11 | $10.92M derived: sum of 2 quarters · filed 2020-05-11 | $15.96M derived: sum of 3 quarters · filed 2020-05-11 | $19.92M derived: sum of 4 quarters · filed 2020-05-11 | |||||
| 2018-12-31 | $5.08M 10-K · filed 2020-03-16 | $10.12M derived: sum of 2 quarters · filed 2020-03-16 | $14.08M derived: sum of 3 quarters · filed 2020-03-16 | $17.25M 10-K · filed 2021-03-12 | |||||
| 2018-09-30 | $5.04M 10-K · filed 2020-03-16 | $9.00M derived: sum of 2 quarters · filed 2020-03-16 | $12.17M 10-Q · filed 2019-11-07 | $15.04M derived: sum of 4 quarters · filed 2020-03-16 | |||||
| 2018-06-30 | $3.96M 10-K · filed 2020-03-16 | $7.14M 10-Q · filed 2019-08-08 | $10.00M derived: sum of 3 quarters · filed 2020-03-16 | $12.92M derived: sum of 4 quarters · filed 2020-03-16 | |||||
| 2018-03-31 | $3.17M 10-K · filed 2020-03-16 | $6.04M derived: sum of 2 quarters · filed 2020-03-16 | $8.96M derived: sum of 3 quarters · filed 2020-03-16 | $11.09M derived: sum of 4 quarters · filed 2020-03-16 | |||||
| 2017-12-31 | $2.86M 10-K · filed 2019-03-14 | $5.79M derived: sum of 2 quarters · filed 2019-03-14 | $7.92M derived: sum of 3 quarters · filed 2019-03-14 | $9.65M 10-K · filed 2020-03-16 | |||||
| 2017-09-30 | $2.92M 10-K · filed 2019-03-14 | $3.20M 10-Q · filed 2017-11-08 | $5.05M derived: sum of 2 quarters · filed 2019-03-14 | $6.78M 10-Q · filed 2018-11-01 | $7.33M 10-Q · filed 2017-11-08 | $8.43M derived: sum of 4 quarters · filed 2019-03-14 | |||
| 2017-06-30 | $2.13M 10-K · filed 2019-03-14 | $2.28M 10-Q · filed 2017-08-10 | $3.86M 10-Q · filed 2018-07-31 | $4.13M 10-Q · filed 2017-08-10 | $5.51M derived: sum of 3 quarters · filed 2019-03-14 | $7.06M derived: sum of 4 quarters · filed 2019-03-14 | |||
| 2017-03-31 | $1.73M 10-K · filed 2019-03-14 | $1.85M 10-Q · filed 2017-05-10 | $3.38M derived: sum of 2 quarters · filed 2019-03-14 | $4.93M derived: sum of 3 quarters · filed 2019-03-14 | $6.36M derived: sum of 4 quarters · filed 2019-03-14 | ||||
| 2016-12-31 | $1.65M 10-K · filed 2018-03-16 | $1.81M 10-K · filed 2017-03-20 | $3.20M derived: sum of 2 quarters · filed 2018-03-16 | $4.63M derived: sum of 3 quarters · filed 2018-03-16 | $5.51M 10-K · filed 2019-03-14 | $5.99M 10-K · filed 2017-03-20 | |||
| 2016-09-30 | $1.55M 10-K · filed 2018-03-16 | $1.74M 10-Q · filed 2016-11-14 | $2.98M derived: sum of 2 quarters · filed 2018-03-16 | $4.18M 10-Q · filed 2017-11-08 | $4.81M derived: sum of 4 quarters · filed 2018-03-16 | ||||
| 2016-06-30 | $1.43M 10-K · filed 2018-03-16 | $1.45M 10-Q · filed 2016-08-10 | $2.44M 10-Q · filed 2017-08-10 | $3.25M derived: sum of 3 quarters · filed 2018-03-16 | $3.91M derived: sum of 4 quarters · filed 2018-03-16 | ||||
| 2016-03-31 | $874.00K 10-K · filed 2018-03-16 | $990.00K 10-Q · filed 2016-06-27 | $1.82M derived: sum of 2 quarters · filed 2018-03-16 | $2.48M derived: sum of 3 quarters · filed 2018-03-16 | $3.03M derived: sum of 4 quarters · filed 2018-03-16 | ||||
| 2015-12-31 | $951.00K 10-K · filed 2017-03-20 | $1.61M derived: sum of 2 quarters · filed 2017-03-20 | $2.16M derived: sum of 3 quarters · filed 2017-03-20 | $2.18M 10-K · filed 2018-03-16 | $2.58M 10-K · filed 2017-03-20 | ||||
| 2015-09-30 | $659.00K 10-K · filed 2017-03-20 | $1.21M derived: sum of 2 quarters · filed 2017-03-20 | $1.63M 10-Q · filed 2016-11-14 | ||||||
| 2015-06-30 | $547.00K 10-K · filed 2017-03-20 | $968.00K 10-Q · filed 2016-08-10 | |||||||
| 2015-03-31 | $421.00K 10-K · filed 2017-03-20 | ||||||||
| 2014-12-31 | $26.00K 10-K · filed 2017-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |